Is Dacomitinib Tablet (Vizimpro) in shortage?
Dacomitinib Tablet is listed by FDA as being discontinued by at least one maker (updated Jun 8, 2026).
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Vizimpro, Tablet, 15 mg (NDC 0069-0197-30)
Discontinuation of the manufacture of the drug
Maker contact: 800-533-4535
- Vizimpro, Tablet, 30 mg (NDC 0069-1198-30)
Discontinuation of the manufacture of the drug
Maker contact: 800-533-4535
- Vizimpro, Tablet, 45 mg (NDC 0069-2299-30)
Discontinuation of the manufacture of the drug
Maker contact: 800-533-4535
Dacomitinib Tablet shortage questions
Is Dacomitinib Tablet (Vizimpro) in shortage?
Dacomitinib Tablet is listed by FDA as being discontinued by at least one maker (updated Jun 8, 2026).
What should I do if I can’t get Dacomitinib Tablet?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.